Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Source:http://linkedlifedata.com/resource/pubmed/id/18794153

Cancer Res. 2008 Sep 15 68 18 7638-49

Download in:

View as

General Info

PMID
18794153